[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-ge-healthcare-stock-at-80-why-analysts-see-35-upside-FR":150},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[],{"post":151,"seo":187,"relatedPosts":194,"suggestedPosts":275},{"id":152,"title":153,"date":154,"modified":155,"excerpt":156,"content":157,"wordCount":158,"lang":159,"uri":160,"slug":161,"cloudinaryAssetId":162,"featuredImageOriginalUrl":163,"featuredImageMetadata":164,"author":167,"editor":173,"categories":178,"relatedPosts":184,"seo":185},95567,"L'action GE Healthcare à 80$ : Pourquoi les analystes voient une hausse de 35 % ?","2026-03-03T19:00:00","2026-03-03T13:56:03","\u003Cp>GEHC vient d'obtenir l'autorisation de la FDA pour trois systèmes d'IRM et de conclure une nouvelle facilité de crédit de 500 millions de dollars, mais le véritable catalyseur, à savoir l'autorisation de Photonova et l'augmentation de la dose de Flyrcado, n'a pas encore eu lieu.\u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-key-stats-for-ge-healthcare-stock\">Statistiques clés pour l'action GE Healthcare\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Performance de la semaine dernière : \u003C\u002Fstrong>+0.05%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Fourchette de 52 semaines : \u003C\u002Fstrong> 57,7 $ à 87,8\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prix actuel : \u003C\u002Fstrong> 80,2\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>La plupart des investisseurs ne savent jamais si une action est réellement sous-évaluée ou surévaluée. Les outils d'évaluation de TIKR, de qualité professionnelle, vous donnent une réponse claire et étayée par des données sur plus de 60 000 actions, et ce, gratuitement.\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">\u003Cstrong>Que s'est-il passé ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Le pipeline d'innovation de\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=1804385326&tid=1816998317&ref=tikrblog\">GEHC\u003C\u002Fa> oblige à un recadrage : l'action à 80,16 $ reflète une société en pleine transformation, et non un nom de dispositif médical mature qui se repose sur sa base installée.\u003C\u002Fp>\n\n\n\n\u003Cp>Le 19 février, la FDA a accordé l'autorisation 510(k) pour trois systèmes d'IRM simultanément : SIGNA Sprint avec Freelium, SIGNA Bolt et SIGNA One, accélérant ainsi la progression de GEHC dans le domaine de l'imagerie de nouvelle génération.\u003C\u002Fp>\n\n\n\n\u003Cp>La croissance organique de PDx a atteint 12,7 % au quatrième trimestre, et Flyrcado a atteint 220 doses hebdomadaires le 23 janvier, soutenant directement l'objectif de revenus de 500 millions de dollars fixé par la direction d'ici la fin de l'année 2028.\u003C\u002Fp>\n\n\n\n\u003Cp>Peter Arduini, président-directeur général, a déclaré lors de l'appel à propos des résultats du quatrième trimestre que \" notre confiance dans notre capacité à générer un chiffre d'affaires de 500 millions de dollars ou plus pour Flyrcado d'ici la fin de l'année 2028 reste intacte \", ce qui correspond directement à l'expansion de la BARDA du 17 février, qui accorde à GEHC environ 35 millions de dollars pour faire progresser l'échographie alimentée par l'intelligence artificielle.\u003C\u002Fp>\n\n\n\n\u003Cp>En outre, la nouvelle facilité de crédit renouvelable de 500 millions de dollars signée le 26 février avec JPMorgan indique que le bilan est prêt à financer la clôture d'Intelerad, une opération qui ajoute 270 millions de dollars de revenus SaaS à forte marge et à croissance à deux chiffres à un portefeuille qui vise déjà 1,8 milliard de dollars de revenus numériques.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez le moment exact où Wall Street revalorise un titre avant que le reste du marché ne le fasse - suivez les changements de notation des analystes en temps réel avec TIKR, gratuitement →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-wall-street-s-take-on-gehc-stock\">\u003Cstrong>Le point de vue de Wall Street sur l'action GEHC\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>L'autorisation accordée par la FDA le 19 février à trois systèmes d'IRM simultanément confirme que le pipeline d'innovation de GEHC convertit les investissements en R&D en produits approuvés et générateurs de revenus avant le cycle d'accélération de 2027.\u003C\u002Fp>\n\n\n\n\u003Cp>Les estimations consensuelles prévoient que le chiffre d'affaires atteindra 21,6 milliards de dollars en 2026, soit une croissance de 4,9 % en glissement annuel, tandis que le BPA augmentera de 10,1 % à 5,06 $, prolongeant une trajectoire qui a vu les marges d'EBITDA se comprimer modestement à 18,1 % en 2025 avant de se redresser à 18,5 %.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"836\" height=\"532\" data-public-id=\"images\u002Fimage-60_955702f1ea\u002Fimage-60_955702f1ea.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_836,h_532,c_scale\u002Ff_webp,q_auto\u002Fv1772545652\u002Fimages\u002Fimage-60_955702f1ea\u002Fimage-60_955702f1ea.png?_i=AA\" alt=\"ge healthcare stock\" class=\"wp-post-95567 wp-image-95570\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772545652\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1772545652\u002Fimages\u002Fimage-60_955702f1ea\u002Fimage-60_955702f1ea.png?_i=AA 836w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_191,c_scale\u002Ff_webp,q_auto\u002Fv1772545652\u002Fimages\u002Fimage-60_955702f1ea\u002Fimage-60_955702f1ea.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_489,c_scale\u002Ff_webp,q_auto\u002Fv1772545652\u002Fimages\u002Fimage-60_955702f1ea\u002Fimage-60_955702f1ea.png?_i=AA 768w\" sizes=\"auto, (max-width: 836px) 100vw, 836px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Cible des analystes de la rue pour l'action GEHC \u003Cstrong>(\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Wall Street indique actuellement 11 achats, 3 surperformances, 6 conservations et 1 vente, avec un objectif de prix moyen de 93,25 $, ce qui implique une hausse de 16,3 % par rapport à la clôture du 2 mars de 80,16 $, les analystes restant convaincus en cas de repli plutôt que de poursuivre le mouvement.\u003C\u002Fp>\n\n\n\n\u003Cp>La fourchette cible des analystes s'étend de 75,00 $ à 110,00 $, le niveau le plus bas dépendant de la poursuite du ralentissement de la Chine et de l'enlisement des mesures d'atténuation des tarifs douaniers, tandis que le niveau le plus élevé dépend de l'approbation de Photonova, de la clôture nette d'Intelerad et de l'augmentation significative des doses de Flyrcado jusqu'au milieu de l'année 2026.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-does-the-valuation-model-say\">\u003Cstrong>Que dit le modèle d'évaluation ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"832\" data-public-id=\"images\u002FGEHC_valuation_model-2_95571d0dae\u002FGEHC_valuation_model-2_95571d0dae.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1772545711\u002Fimages\u002FGEHC_valuation_model-2_95571d0dae\u002FGEHC_valuation_model-2_95571d0dae.webp?_i=AA\" alt=\"ge healthcare stock\" class=\"wp-post-95567 wp-image-95571\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772545711\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1772545711\u002Fimages\u002FGEHC_valuation_model-2_95571d0dae\u002FGEHC_valuation_model-2_95571d0dae.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_244,c_scale\u002Ff_webp,q_auto\u002Fv1772545711\u002Fimages\u002FGEHC_valuation_model-2_95571d0dae\u002FGEHC_valuation_model-2_95571d0dae.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_624,c_scale\u002Ff_webp,q_auto\u002Fv1772545711\u002Fimages\u002FGEHC_valuation_model-2_95571d0dae\u002FGEHC_valuation_model-2_95571d0dae.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1248,c_scale\u002Ff_webp,q_auto\u002Fv1772545711\u002Fimages\u002FGEHC_valuation_model-2_95571d0dae\u002FGEHC_valuation_model-2_95571d0dae.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1663,c_scale\u002Ff_webp,q_auto\u002Fv1772545711\u002Fimages\u002FGEHC_valuation_model-2_95571d0dae\u002FGEHC_valuation_model-2_95571d0dae.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_975,c_scale\u002Ff_webp,q_auto\u002Fv1772545711\u002Fimages\u002FGEHC_valuation_model-2_95571d0dae\u002FGEHC_valuation_model-2_95571d0dae.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1137,c_scale\u002Ff_webp,q_auto\u002Fv1772545711\u002Fimages\u002FGEHC_valuation_model-2_95571d0dae\u002FGEHC_valuation_model-2_95571d0dae.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Résultats du modèle d'évaluation des actions de GEHC \u003Cstrong>(\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=21127&tid=2621295&ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Le modèle d'évaluation TIKR vise 109,71 $ d'ici le 31 décembre 2030, ce qui implique un rendement total de 36,9 % et un TRI de 6,7 % par rapport aux niveaux actuels, un écart que le marché n'a pas encore évalué.\u003C\u002Fp>\n\n\n\n\u003Cp>Le marché considère GEHC comme une société d'appareils à croissance lente, alors que son segment PDx à lui seul a connu une croissance organique de 12,7% au 4ème trimestre.\u003C\u002Fp>\n\n\n\n\u003Cp>L'acquisition d'Intelerad ajoute 270 millions de dollars de revenus SaaS avec une croissance à deux chiffres, un profil de revenus récurrents que le multiple actuel de l'action ne reflète pas encore.\u003C\u002Fp>\n\n\n\n\u003Cp>Le système Heartbeat de la direction a déjà permis une amélioration mensuelle de 25% du carnet de commandes en souffrance, signalant un effet de levier opérationnel que les estimations de marge du consensus sous-estiment probablement.\u003C\u002Fp>\n\n\n\n\u003Cp>La baisse du budget de la Chine en 2026, combinée à un pic tarifaire au premier trimestre, pourrait comprimer les BPA à court terme en dessous du consensus de 5,06 $ si les efforts d'atténuation stagnent, ce qui mettrait en péril l'objectif de croissance de 8 à 12 % pour l'ensemble de l'année.\u003C\u002Fp>\n\n\n\n\u003Cp>La trajectoire de la dose hebdomadaire de Flyrcado au cours du deuxième trimestre déterminera si l'objectif de 500 millions de dollars de revenus pour 2028 reste crédible et si PDx maintient une croissance organique à deux chiffres.\u003C\u002Fp>\n\n\n\n\u003Cp>GEHC se négocie comme sous-évaluée à 80,16 $, avec une réaccélération des bénéfices en 2027 et un objectif implicite de 109,71 $, ce qui fait du prix actuel un point d'entrée patient.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Les meilleures idées de Wall Street ne restent pas cachées longtemps. Surveillez les mises à jour des analystes, les résultats supérieurs aux attentes et les surprises en matière de revenus pour des milliers d'actions dès qu'elles se produisent grâce à TIKR gratuitement →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-should-you-invest-in-ge-healthcare-technologies-inc\">\u003Cstrong>Devriez-vous investir dans GE Healthcare Technologies, Inc.\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>La seule façon de le savoir est d'examiner les chiffres vous-même. TIKR vous donne un accès gratuit aux mêmes données financières de qualité institutionnelle que celles utilisées par les analystes professionnels pour répondre à cette question.\u003C\u002Fp>\n\n\n\n\u003Cp>En consultant l'action GEHC, vous verrez des années de données financières historiques, les prévisions des analystes de Wall Street en matière de revenus et de bénéfices pour les trimestres à venir, l'évolution des multiples d'évaluation au fil du temps et la tendance à la hausse ou à la baisse des objectifs de prix.\u003C\u002Fp>\n\n\n\n\u003Cp>Vous pouvez créer une liste de surveillance gratuite pour suivre GE Healthcare Technologies, Inc. en même temps que toutes les autres actions qui vous intéressent. Aucune carte de crédit n'est requise. Juste les données dont vous avez besoin pour décider par vous-même.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Accédez gratuitement à des outils professionnels pour analyser l'action GEHC sur TIKR →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n",761,"fr","\u002Fblog\u002Fge-healthcare-stock-at-80-why-analysts-see-35-upside","ge-healthcare-stock-at-80-why-analysts-see-35-upside","images\u002FFEATURED-IMAGE-MAKER-392\u002FFEATURED-IMAGE-MAKER-392","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772545982\u002Fimages\u002FFEATURED-IMAGE-MAKER-392\u002FFEATURED-IMAGE-MAKER-392.png?_i=AA",{"altText":165,"imageCredit":166},"GE Healthcare Stock at 80$: Why Analysts See 35% Upside","TIKR",{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":172},"Gian Estrada","giantikr","author","",[],{"name":174,"slug":175,"role":176,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":177},"Thomas Richmond","thomastikr","editor",[],[179],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":165,"metaDesc":186,"opengraphDescription":186,"twitterTitle":165,"twitterDescription":186},"GEHC just secured FDA clearance for three MRI systems and locked a new $500 million credit facility, but the real catalyst, Photonova approval and Flyrcado’s dose ramp, has not even hit yet.",{"title":165,"description":188,"twitterTitle":165,"twitterDescription":188,"author":168,"articlePublisher":189,"articlePublishedTime":154,"articleModifiedTime":155,"twitterLabel1":190,"twitterData1":191,"ogTitle":165,"ogDescription":188,"ogUrl":160,"ogImage":163,"ogImageWidth":192,"ogImageHeight":193,"ogImageSecureUrl":163,"ogImageAlt":165,"twitterImage":163},"GEHC just secured FDA clearance for three MRI systems and locked a new $500 million credit facility, but the real catalyst, Photonova approval and Flyrcado’s dose ramp, has not even hit yet.","TIKR.com","Temps de lecture estimé","6 minutes",1200,630,[195,212,227,245,260],{"id":183,"title":196,"date":197,"excerpt":198,"wordCount":199,"uri":200,"slug":201,"cloudinaryAssetId":202,"featuredImageOriginalUrl":203,"featuredImageMetadata":204,"author":205,"categories":209,"relatedPosts":211},"L'action RCUS bondit de 17,5 % malgré une perte nette de 353 millions de dollars : ce que la juste valeur de 34 $ indique","2026-03-03 19:00:00","Voici pourquoi l'action d'Arcus Biosciences a bondi de 17,5 % à 24 $, les données cliniques et une trésorerie de 981 millions de dollars ayant compensé les pertes croissantes.",660,"\u002Fblog\u002Frcus-stock-jumps-17-5-despite-353m-net-loss-what-34-fair-value-signals","rcus-stock-jumps-17-5-despite-353m-net-loss-what-34-fair-value-signals","images\u002FRCUS-stock\u002FRCUS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772563814\u002Fimages\u002FRCUS-stock\u002FRCUS-stock.png?_i=AA",{"altText":196},{"name":206,"slug":207,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":208},"Rexielyn Diaz","rexietikr",[],[210],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":213,"date":214,"excerpt":215,"wordCount":216,"uri":217,"slug":218,"cloudinaryAssetId":219,"featuredImageOriginalUrl":220,"featuredImageMetadata":221,"author":222,"categories":224,"relatedPosts":226},"L'action AXT bondit de 22% à 46 dollars : pourquoi les analystes voient toujours une juste valeur de 27 dollars","2026-03-03 18:50:00","Voici pourquoi l'action AXT a bondi de 22,2 % pour atteindre 46 $, les investisseurs regardant au-delà des faibles marges et vers une croissance prévue de 42 % du chiffre d'affaires.",674,"\u002Fblog\u002Faxt-stock-surges-22-to-46-why-analysts-still-see-27-fair-value","axt-stock-surges-22-to-46-why-analysts-still-see-27-fair-value","images\u002FAXTI-stock\u002FAXTI-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772562833\u002Fimages\u002FAXTI-stock\u002FAXTI-stock.png?_i=AA",{"altText":213},{"name":206,"slug":207,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":223},[],[225],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":228,"date":229,"excerpt":230,"wordCount":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":238,"categories":242,"relatedPosts":244},"Johnson & Johnson a progressé de 38% au cours des 6 derniers mois. Voici ce que l'action pourrait devenir en 2026","2026-03-03 18:35:00","Johnson & Johnson a bondi d'environ 38 % au cours des six derniers mois, et notre analyse suggère que le titre pourrait encore offrir une hausse régulière jusqu'en 2026. Voici pourquoi l'accélération de la croissance de l'oncologie et l'expansion des marges continuent de soutenir la configuration.",691,"\u002Fblog\u002Fjohnson-johnson-has-rallied-38-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","johnson-johnson-has-rallied-38-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","images\u002F@Sergiu-Rusus-Images-via-Canva\u002F@Sergiu-Rusus-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772549656\u002Fimages\u002F@Sergiu-Rusus-Images-via-Canva\u002F@Sergiu-Rusus-Images-via-Canva.png?_i=AA",{"altText":237},"Johnson & Johnson a progressé de 38% au cours des 6 derniers mois. Voici ce que l'action pourrait devenir en 2026",{"name":239,"slug":240,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":241},"Nikko Henson","nikkotikr",[],[243],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":246,"date":247,"excerpt":248,"wordCount":249,"uri":250,"slug":251,"cloudinaryAssetId":252,"featuredImageOriginalUrl":253,"featuredImageMetadata":254,"author":255,"categories":257,"relatedPosts":259},"L'action d'Applied Optoelectronics a bondi de 22% cette semaine : Pourquoi les analystes voient une juste valeur de 48","2026-03-03 18:30:00","Voici pourquoi l'action d'Applied Optoelectronics oscille après les résultats et pourquoi les analystes voient encore une hausse jusqu'à 55 $.",718,"\u002Fblog\u002Fapplied-optoelectronics-stock-jumps-22-this-week-why-analysts-see-48-fair-value","applied-optoelectronics-stock-jumps-22-this-week-why-analysts-see-48-fair-value","images\u002FAAOI-stock_956327ccae\u002FAAOI-stock_956327ccae","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772561795\u002Fimages\u002FAAOI-stock_956327ccae\u002FAAOI-stock_956327ccae.png?_i=AA",{"altText":246},{"name":206,"slug":207,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":256},[],[258],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":261,"date":262,"excerpt":263,"wordCount":264,"uri":265,"slug":266,"cloudinaryAssetId":267,"featuredImageOriginalUrl":268,"featuredImageMetadata":269,"author":270,"categories":272,"relatedPosts":274},"IQVIA a progressé de 7 % cette semaine. Voici où l'action pourrait se situer en 2026","2026-03-03 18:05:00","L'action IQVIA a progressé d'environ 7 % cette semaine, et notre analyse suggère que le titre pourrait encore offrir une hausse significative en 2026. Voici pourquoi une croissance commerciale régulière, une demande clinique résiliente et des capacités d'IA en expansion continuent de soutenir la configuration.",735,"\u002Fblog\u002Fiqvia-rose-7-this-week-heres-where-the-stock-could-head-in-2026","iqvia-rose-7-this-week-heres-where-the-stock-could-head-in-2026","images\u002F@SOMKID-THONGDEE-from-Getty-Images-via-Canva-223\u002F@SOMKID-THONGDEE-from-Getty-Images-via-Canva-223","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772547778\u002Fimages\u002F@SOMKID-THONGDEE-from-Getty-Images-via-Canva-223\u002F@SOMKID-THONGDEE-from-Getty-Images-via-Canva-223.png?_i=AA",{"altText":261},{"name":239,"slug":240,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":271},[],[273],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],[276,296,311,326,343,358,376,390,405,419],{"id":183,"title":277,"date":278,"excerpt":279,"wordCount":280,"uri":281,"slug":282,"cloudinaryAssetId":283,"featuredImageOriginalUrl":284,"featuredImageMetadata":285,"author":286,"categories":290,"relatedPosts":295},"Barclays ramène la note de l'action Blue Owl à \"Equal Weight\" alors que la chute du cours de l'action se poursuit","2026-03-03 11:59:00","Barclays abaisse la note de Blue Owl Capital en raison d'un fort ralentissement des entrées de capitaux dans les BDC non cotées et d'une forte augmentation des rachats. L'action a baissé de 50 % au cours de l'année écoulée en raison des craintes liées au crédit.",775,"\u002Fblog\u002Fbarclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","barclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","images\u002FOWL-stock-1\u002FOWL-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772533744\u002Fimages\u002FOWL-stock-1\u002FOWL-stock-1.png?_i=AA",{"altText":277},{"name":287,"slug":288,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":289},"Aditya Raghunath","adityatikr",[],[291],{"name":292,"slug":293,"uri":294,"description":171,"postsCount":183},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":183,"title":297,"date":298,"excerpt":299,"wordCount":300,"uri":301,"slug":302,"cloudinaryAssetId":303,"featuredImageOriginalUrl":304,"featuredImageMetadata":305,"author":306,"categories":308,"relatedPosts":310},"L'action Novo Nordisk atteint son plus bas niveau en 52 semaines, Goldman Sachs la rétrograde à \"neutre\".","2026-03-03 10:55:00","L'action Block a augmenté de plus de 20 % après que la société fintech a annoncé qu'elle allait licencier plus de 4 000 employés, soit environ la moitié de ses effectifs.",655,"\u002Fblog\u002Fnovo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","novo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","images\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772532602\u002Fimages\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1.png?_i=AA",{"altText":297},{"name":287,"slug":288,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":307},[],[309],{"name":292,"slug":293,"uri":294,"description":171,"postsCount":183},[],{"id":183,"title":312,"date":313,"excerpt":314,"wordCount":315,"uri":316,"slug":317,"cloudinaryAssetId":318,"featuredImageOriginalUrl":319,"featuredImageMetadata":320,"author":321,"categories":323,"relatedPosts":325},"Le financement massif d'OpenAI déclenche la chute de l'action d'Amazon","2026-03-02 10:30:00","L'action d'Amazon a chuté après la levée de fonds de 110 milliards de dollars d'OpenAI, malgré l'engagement d'Amazon à hauteur de 50 milliards de dollars et la conclusion d'un accord de partenariat majeur avec AWS.",831,"\u002Fblog\u002Fopenai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","openai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","images\u002FAMZN-stock-1\u002FAMZN-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772278707\u002Fimages\u002FAMZN-stock-1\u002FAMZN-stock-1.png?_i=AA",{"altText":312},{"name":287,"slug":288,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":322},[],[324],{"name":292,"slug":293,"uri":294,"description":171,"postsCount":183},[],{"id":183,"title":327,"date":328,"excerpt":329,"wordCount":330,"uri":331,"slug":332,"cloudinaryAssetId":333,"featuredImageOriginalUrl":334,"featuredImageMetadata":335,"author":336,"categories":340,"relatedPosts":342},"L'action Chime bondit de 14 % sur la voie de la rentabilité selon les GAAP : voici où l'action pourrait se diriger en 2026","2026-03-01 15:00:00","Les actions de Chime Financial (CHYM) sont en train d'enregistrer une forte hausse après la publication de leurs résultats, suite à la publication d'un rapport sur le quatrième trimestre qui a fait date.",743,"\u002Fblog\u002Fchime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","chime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","images\u002F21-2\u002F21-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322176\u002Fimages\u002F21-2\u002F21-2.png?_i=AA",{"altText":327},{"name":337,"slug":338,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":339},"Wiltone Asuncion","wiltonetikr",[],[341],{"name":292,"slug":293,"uri":294,"description":171,"postsCount":183},[],{"id":183,"title":344,"date":345,"excerpt":346,"wordCount":347,"uri":348,"slug":349,"cloudinaryAssetId":350,"featuredImageOriginalUrl":351,"featuredImageMetadata":352,"author":353,"categories":355,"relatedPosts":357},"L'action de Crescent Energy bondit de 7 % grâce à des synergies doublées dans le Permien : Voici où l'action pourrait aller en 2026","2026-03-01 14:50:00","Crescent Energy Company (CRGY) aborde l'année 2026 en tant qu'opérateur multi-bassins à grande échelle, après avoir réalisé des transactions d'une valeur de près de 5 milliards de dollars. ",816,"\u002Fblog\u002Fcrescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","crescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","images\u002F20-2\u002F20-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322164\u002Fimages\u002F20-2\u002F20-2.png?_i=AA",{"altText":344},{"name":337,"slug":338,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":354},[],[356],{"name":292,"slug":293,"uri":294,"description":171,"postsCount":183},[],{"id":183,"title":359,"date":360,"excerpt":361,"wordCount":362,"uri":363,"slug":364,"cloudinaryAssetId":365,"featuredImageOriginalUrl":366,"featuredImageMetadata":367,"author":368,"categories":370,"relatedPosts":375},"En baisse de 25 % par rapport à son plus haut niveau historique, l'action Capital One peut-elle offrir de meilleurs rendements en 2026 ?","2026-03-03 11:25:00","L'action Capital One pourrait générer des rendements de 30 % d'ici 2028, l'intégration de Discover et l'acquisition de Brex débloquant la croissance du réseau de paiements et l'expansion des services bancaires aux entreprises.",1309,"\u002Fblog\u002Fdown-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","down-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","images\u002FCOF-stock\u002FCOF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772516734\u002Fimages\u002FCOF-stock\u002FCOF-stock.png?_i=AA",{"altText":359},{"name":287,"slug":288,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":369},[],[371],{"name":372,"slug":373,"uri":374,"description":171,"postsCount":183},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":183,"title":377,"date":298,"excerpt":378,"wordCount":379,"uri":380,"slug":381,"cloudinaryAssetId":382,"featuredImageOriginalUrl":383,"featuredImageMetadata":384,"author":385,"categories":387,"relatedPosts":389},"En hausse de 20 % au cours des 12 derniers mois, l'action Synchrony Financial peut-elle évoluer à la hausse en 2026 ?","En hausse de 20% sur 12 mois, Synchrony Financial est prometteur avec la croissance du partenariat avec Walmart. Notre modèle prévoit une hausse de 27 % à 87 $ d'ici décembre 2028. Analyse à l'intérieur.",1261,"\u002Fblog\u002Fup-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","up-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","images\u002FSYF-stock\u002FSYF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772512295\u002Fimages\u002FSYF-stock\u002FSYF-stock.png?_i=AA",{"altText":377},{"name":287,"slug":288,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":386},[],[388],{"name":372,"slug":373,"uri":374,"description":171,"postsCount":183},[],{"id":183,"title":391,"date":392,"excerpt":393,"wordCount":394,"uri":395,"slug":396,"cloudinaryAssetId":397,"featuredImageOriginalUrl":398,"featuredImageMetadata":399,"author":400,"categories":402,"relatedPosts":404},"En hausse de 42 % en 3 ans, l'action de Raymond James Financial peut-elle continuer à progresser ?","2026-03-03 09:55:00","L'action Raymond James a baissé de 10 % en 12 mois. Un fort recrutement, 31 milliards de dollars de nouveaux actifs nets signalent une reprise. Notre modèle prévoit une hausse de 21 % pour atteindre 185 $ d'ici septembre 2028.",1234,"\u002Fblog\u002Fup-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","up-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","images\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772467602\u002Fimages\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878.png?_i=AA",{"altText":391},{"name":287,"slug":288,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":401},[],[403],{"name":372,"slug":373,"uri":374,"description":171,"postsCount":183},[],{"id":183,"title":406,"date":392,"excerpt":407,"wordCount":408,"uri":409,"slug":410,"cloudinaryAssetId":411,"featuredImageOriginalUrl":412,"featuredImageMetadata":413,"author":414,"categories":416,"relatedPosts":418},"En hausse de 19 % au cours des 12 derniers mois, les valeurs financières régionales peuvent-elles encore progresser en 2026 ?","Des bénéfices solides au quatrième trimestre et un taux de rendement des capitaux propres de 18 % placent Regions Financial en position de croissance. Notre modèle prévoit une hausse de 26 % pour atteindre 35 $ d'ici 2028. L'action RF peut-elle tenir ses promesses en 2026 ?",1264,"\u002Fblog\u002Fup-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","up-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","images\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772446487\u002Fimages\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63.png?_i=AA",{"altText":406},{"name":287,"slug":288,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":415},[],[417],{"name":372,"slug":373,"uri":374,"description":171,"postsCount":183},[],{"id":183,"title":420,"date":421,"excerpt":422,"wordCount":423,"uri":424,"slug":425,"cloudinaryAssetId":426,"featuredImageOriginalUrl":427,"featuredImageMetadata":428,"author":429,"categories":431,"relatedPosts":433},"En baisse de 65 % par rapport à son plus haut niveau historique, l'action Brown-Forman peut-elle offrir de meilleurs résultats en 2026 ?","2026-03-03 09:45:00","L'action Brown-Forman pourrait atteindre 36 dollars d'ici 2028 grâce au succès du Blackberry de Jack Daniel et à la croissance des marchés émergents, malgré des vents contraires à court terme dans le secteur de la consommation.",1334,"\u002Fblog\u002Fdown-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","down-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","images\u002FBFB-stock\u002FBFB-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772433508\u002Fimages\u002FBFB-stock\u002FBFB-stock.png?_i=AA",{"altText":420},{"name":287,"slug":288,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":430},[],[432],{"name":372,"slug":373,"uri":374,"description":171,"postsCount":183},[]]